Detalhe da pesquisa
1.
A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor.
Eur J Clin Pharmacol
; 79(8): 1073-1080, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37278823
2.
In vitro metabolism, pharmacokinetics and drug interaction potentials of emvododstat, a DHODH inhibitor.
Xenobiotica
; 52(2): 152-164, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34846990
3.
LC-MS/MS methods for direct measurement of sepiapterin and tetrahydrobiopterin in human plasma and clinical applications.
Bioanalysis
; 16(2): 75-89, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38099558
4.
Relative Oral Bioavailability and Food Effects of Two Sepiapterin Formulations in Healthy Participants.
Clin Pharmacol Drug Dev
; 13(5): 506-516, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38156759
5.
Validation and application of volumetric absorptive microsampling (VAMS) dried blood method for phenylalanine measurement in patients with phenylketonuria.
Clin Biochem
; 116: 65-74, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001750
6.
A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti-SARS-CoV-2 (COVID-19) DHODH (dihydroorotate dehydrogenase) inhibitor.
Pharmacol Res Perspect
; 11(2): e01076, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36938928
7.
First-in-Human Studies of Pharmacokinetics and Safety of Utreloxastat (PTC857), a Novel 15-Lipooxygenase Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis.
Clin Pharmacol Drug Dev
; 12(2): 141-151, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516010
8.
Pharmacokinetics of Dacarbazine and Unesbulin and CYP1A2-Mediated Drug Interactions in Patients With Leiomyosarcoma.
Clin Transl Sci
; 2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129988
9.
Effects of quercetin supplementation on markers of muscle damage and inflammation after eccentric exercise.
Int J Sport Nutr Exerc Metab
; 22(6): 430-7, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22805422
10.
Pharmacokinetics and Safety of PTC596, a Novel Tubulin-Binding Agent, in Subjects With Advanced Solid Tumors.
Clin Pharmacol Drug Dev
; 10(8): 940-949, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33440067
11.
Effect of quercetin supplementation on maximal oxygen uptake in men and women.
J Sports Sci
; 28(2): 201-8, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20054739
12.
Percutaneous penetration modifiers and formulation effects: thermal and spectral analyses.
AAPS PharmSciTech
; 11(3): 1068-83, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20582492
13.
LC-MS/MS quantification of ataluren and ataluren acyl glucuronide in human plasma/urine: application in clinical studies.
Bioanalysis
; 12(21): 1545-1555, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064028
14.
Metabolite V, an epoxide species is a minor circulating metabolite in humans following a single oral dose of deflazacort.
Pharmacol Res Perspect
; 8(6): e00677, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090712
15.
Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects.
Clin Pharmacol Drug Dev
; 8(2): 172-178, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30629861
16.
Percutaneous permeation modifiers: enhancement versus retardation.
Expert Opin Drug Deliv
; 5(5): 517-29, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18491979
17.
Study of self-organized CdS Q-dots.
J Nanosci Nanotechnol
; 8(8): 4303-8, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19049222
18.
Self-organized ZnSe quantum dots: synthesis and characterization.
J Nanosci Nanotechnol
; 8(3): 1502-11, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18468182
19.
Comparison of quercetin pharmacokinetics following oral supplementation in humans.
J Food Sci
; 77(11): H231-8, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23094941
20.
Percutaneous penetration modifiers and formulation effects.
Int J Pharm
; 386(1-2): 42-51, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19900521